Ivan Šnajdr

Všechny publikace

Nejnovější publikace

Discovery of Orally Available Prodrugs of Itaconate and Derivatives

C. B. Lee I. Šnajdr L. Tenora J. Alt S. Gori M. Krečmerová R. M. Maragakis J. Paule S. Tiwari J. Iyer R. Talwar L. Garza P. Majer B. S. Slusher R. Rais

Journal of Medicinal Chemistry 68 (3): 3433–3444 (2025)

Discovery of tert-Butyl Ester Based 6-Diazo-5-oxo-L-norleucine Prodrugs for Enhanced Metabolic Stability and Tumor Delivery

K. Novotná L. Tenora E. Prchalová J. Paule J. Alt V. Veeravalli J. Lam Y. Wu I. Šnajdr S. Gori V. S. Mettu T. Tsukamoto P. Majer B. S. Slusher R. Rais

Journal of Medicinal Chemistry 66 (22): 15493–15510 (2023)

A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis

D. E. Peters L. D. Norris L. Tenora I. Šnajdr A. K. Ponti X. Zhu S. Sakamoto V. Veeravalli M. Pradhan J. Alt A. G. Thomas M. Majer R. Rais C. McDonald B. S. Slusher

Science Translational Medicine 15 (708): eabn7491 (2023)

Comprehensive Mechanistic View of the Hydrolysis of Oxadiazole-Based Inhibitors by Histone Deacetylase 6 (HDAC6)

L. Motlová I. Šnajdr Z. Kutil E. Andris J. Ptáček A. Novotná Z. Nováková B. Havlínová W. Tueckmantel H. Dráberová P. Majer M. Schutkowski A. Kozikowski L. Rulíšek C. Bařinka

ACS Chemical Biology 18 (7): 1594–1610 (2023)